The findings showed that using bispecific Ab (anti-EGFR and anti-c-Met) could suppress growth in anti-EGFR resistant cells more efficiently compared to anti-EGFR agents, such as gefitinib, erlotinib, and so on [149]
Example: If a patient is treated for Type 2 Diabetes with complications and receives insulin therapy: Diagnosis Code (ICD-10-CM): E11.65 (Type 2 diabetes mellitus with hyperglycemia) Procedure Code (CPT): 96372 (Injection, subcutaneous) Supply Code (HCPCS): J1815 (Injection, insulin, per 5 units) In short: Medical coding = Converting healthcare into universal codes for proper documentation, billing, and patient care
If fatigue prevents you from working, driving safely, or caring for yourself, contact your healthcare team promptly
Theres only one phase one trial thats registered right now, and its been registered since 2016, and nothing has been updated on that registration, so that tells you something as well